Showing results (321-330 of 415) with videos related to
Sort By:
Pageof 42
Blood|October 27, 2023
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001Jeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.Osteoarthritis and Cartilage|February 23, 2010
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009W Zhang, G Nuki, R W Moskowitz, et al.Nature Biomedical Engineering|December 18, 2018
Design and clinical validation of a point-of-care device for the diagnosis of lymphoma via contrast-enhanced microholography and machine learningHyungsoon Im, Divya Pathania, Philip J McFarland, et al.Clinical Immunology (Orlando, Fla.)|May 5, 1999
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthmaJ L Kishiyama, D Valacer, C Cunningham-Rundles, et al.Medical and Pediatric Oncology|July 24, 2001
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of ageN K Cheung, B H Kushner, M LaQuaglia, et al.Blood|December 21, 2022
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM studyJeremy S Abramson, Scott R Solomon, Jon Arnason, et al.Cancer|November 14, 2015
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphomaDaniel J Landsburg, Adam M Petrich, Jeremy S Abramson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2023
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design StudyMichael Wang, Tanya Siddiqi, Leo I Gordon, et al.Critical Care Medicine|February 1, 1996
Cerebral resuscitation from cardiac arrest: treatment potentialsS E Gisvold, F Sterz, N S Abramson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapyJ S Abramson, T Feldman, A R Kroll-Desrosiers, et al.Pageof 42